Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q4 2022 Earnings Call Transcript March 10, 2023
Operator: Welcome to the Acorda Therapeutics Fourth Quarter and Year-End 2022 Financial and Business Update. Please be advised that this call is being recorded at the company’s request. I will now introduce your host for today’s call, Tierney Saccavino, at Acorda. Tierney, please go ahead.
Tierney Saccavino : Thank you, Emily, and good morning, everyone. So before we begin, let me remind you that our...
